Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
Open Access
- 23 January 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 13 (1), 29
- https://doi.org/10.1186/1471-2334-13-29
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United StatesMycoses, 2011
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2008
- Comparison of the Use of Administrative Data and an Active System for Surveillance of Invasive AspergillosisInfection Control & Hospital Epidemiology, 2008
- Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patientsIntensive Care Medicine, 2007
- A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999Journal of Antimicrobial Chemotherapy, 2004
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- A QUANTITATIVE METHOD FOR COST REIMBURSEMENT AND LENGTH OF STAY QUALITY ASSURANCE IN MULTIPLE TRAUMA PATIENTSThe Journal of Trauma and Acute Care Surgery, 1994
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Effect of Pre-existing Disease on Length of Hospital Stay in Trauma PatientsThe Journal of Trauma and Acute Care Surgery, 1989
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987